These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 12850761)

  • 21. Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives.
    Vanni T; Sprinz E; Machado MW; Santana Rde C; Fonseca BA; Schwartsmann G
    Cancer Treat Rev; 2006 Oct; 32(6):445-55. PubMed ID: 16860939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kaposi's sarcoma: an update.
    Schwartz RA
    J Surg Oncol; 2004 Sep; 87(3):146-51. PubMed ID: 15334644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of foscarnet on HIV-associated Kaposi's sarcoma derived cell lines.
    Willers CP; Reimann G; Mertins L; Brockmeyer NH
    Eur J Med Res; 1999 Dec; 4(12):514-6. PubMed ID: 10611055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic treatment of Kaposi's sarcoma: current status and future directions.
    Lilenbaum RC; Ratner L
    AIDS; 1994 Feb; 8(2):141-51. PubMed ID: 7519018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-talk between human herpesvirus 8 and the transactivator protein in the pathogenesis of Kaposi's sarcoma in HIV-infected patients.
    Chandra A; Demirhan I; Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Linde A; Heiden T; Biberfeld P; Doerr HW; Cinatl J; Loewer J; Chandra P
    Anticancer Res; 2003; 23(1B):723-8. PubMed ID: 12680174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
    Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
    Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of human herpesvirus 8 in the pathogenesis of Kaposi's sarcoma.
    Blauvelt A
    Adv Dermatol; 1999; 14():167-206; discussion 207. PubMed ID: 10643499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Successful treatment with liposomal doxorubicin and foscarnet in a patient with widespread Kaposi's sarcoma and human herpes virus 8-related, serious hemophagocytic syndrome, after renal transplantation].
    Bossini N; Sandrini S; Setti G; Luppi M; Maiorca P; Maffei C; Cancarini G
    G Ital Nefrol; 2005; 22(3):281-6. PubMed ID: 16001371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exclusive penile Kaposi's sarcoma: report of an HIV-negative man successfully treated with radiotherapy.
    Zargari O
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):318-20. PubMed ID: 16503896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New drug targets in Kaposi sarcoma.
    Sullivan RJ; Pantanowitz L
    Expert Opin Ther Targets; 2010 Dec; 14(12):1355-66. PubMed ID: 21043836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-associated Kaposi sarcoma: pathogenic mechanisms.
    Feller L; Wood NH; Lemmer J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Oct; 104(4):521-9. PubMed ID: 17142074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of human herpes virus type 8-associated diseases by NK cells.
    Sirianni MC; Campagna M; Scaramuzzi D; Carbonari M; Toschi E; Bacigalupo I; Monini P; Ensoli B
    Ann N Y Acad Sci; 2007 Jan; 1096():37-43. PubMed ID: 17405914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era.
    La Ferla L; Pinzone MR; Nunnari G; Martellotta F; Lleshi A; Tirelli U; De Paoli P; Berretta M; Cacopardo B
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2354-65. PubMed ID: 24065230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased immunoreactivity for cell-cycle regulator p27(Kip1) in Kaposi's sarcoma correlates with higher stage and extracutaneous involvement.
    Fernández-Figueras MT; Puig L; Penín RM; Mate JL; Bigatà X; Ariza A
    J Pathol; 2000 Aug; 191(4):387-93. PubMed ID: 10918213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human herpesvirus 8: current issues.
    Cannon MJ; Laney AS; Pellett PE
    Clin Infect Dis; 2003 Jul; 37(1):82-7. PubMed ID: 12830412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Kaposi's sarcoma in resource-limited settings in the era of HAART.
    Lynen L; Zolfo M; Huyst V; Louis F; Barnardt P; Van de Velde A; De Schacht C; Colebunders R
    AIDS Rev; 2005; 7(1):13-21. PubMed ID: 15875657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signal transduction targets in Kaposi's sarcoma.
    Sullivan R; Dezube BJ; Koon HB
    Curr Opin Oncol; 2006 Sep; 18(5):456-62. PubMed ID: 16894293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
    Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
    Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wide-ranging progress on KS therapies.
    Horn T; Gilden D
    GMHC Treat Issues; 1998 Feb; 12(2):8-16. PubMed ID: 11365219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Kaposi's sarcoma].
    Polák P; Snopková S; Husa P; Povolná K; Bohatá S; Moulis M
    Klin Mikrobiol Infekc Lek; 2010 Oct; 16(5):172-8. PubMed ID: 21191875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.